BCYC
7:00 AM
Bicycle Therapeutics Reports Recent Business Progress and Second Quarter 2026 Financial Results
Data presented at AACR and ASCO provide further validation of the potential of Bicycle ® technology to deliver oncology therapeutics with improved benefit/risk profiles compared to existing modalities Expanded Clinical Advisory Board with the addition of Thomas Powles, MBBS, MRCP, M.D.
Presentation / Abstract • Phase 2bicycletherapeutics.com